Lv4
468 积分 2024-12-19 加入
Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
1个月前
已完结
Diterpenoids from Mangrove Plant Excoecaria agallocha L. and Their Anti-neuroinflammatory Activities
2个月前
已完结
Ent-eudesmane sesquiterpenoids with anti-neuroinflammatory activity from the marine-derived fungus Eutypella sp. F0219
2个月前
已完结
Using Models to Support Argumentation in the Science Classroom
3个月前
已完结
Discovery of Potent Dual PROTAC Degraders Targeting BET-Kinase To Overcome FLT3 Inhibitor Resistance
5个月前
已完结
Non-Covalent Cathepsin K Inhibitors for the Treatment of Osteoporosis
6个月前
已完结
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
9个月前
已完结
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
11个月前
已完结
Discovery of APH02174 as a Highly Selective and Orally Bioavailable IRAK4 Degrader for the Treatment of Inflammatory Diseases
11个月前
已完结
Monoclonal antibodies for the treatment of atopic dermatitis
11个月前
已完结
皖公网安备34019202002308
